Estimating the Economic Consequences of Leveraging the Novel cobas HIV-1/HIV-2 Qualitative Nucleic Acid Amplification Test in Routine HIV Testing

The study demonstrates a significant reduction in the number of cumulative tests needed to diagnose HIV accurately while remaining cost neutral to payers using the alternative algorithm. These findings suggest that the proposed alternative algorithm can streamline HIV testing without a substantial increase in healthcare costs and minimize adverse patient outcomes.

Authors

Institutions

Publication Details

Journal
Clinical Infectious Diseases
Published
2025-01-29
DOI
https://doi.org/10.1093/cid/ciaf025
Primary Topic
HIV/AIDS Impact and Responses
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Estimating the Economic Consequences of Leveraging the Novel cobas HIV-1/HIV-2 Qualitative Nucleic Acid Amplification Test in Routine HIV Testing

James Karichu, Sara J. Blosser, Kwaku D. Tawiah, S. Pinar Bilir et al.
2 links
Clinical Infectious Diseases
HIV/AIDS Impact and Responses
article

Estimating the Economic Consequences of Leveraging the Novel cobas HIV-1/HIV-2 Qualitative Nucleic Acid Amplification Test in Routine HIV Testing

James Karichu, Sara J. Blosser, Kwaku D. Tawiah, S. Pinar Bilir, Tamar Tchelidze, D. Tarruella Hernández, Cheryl P Ferrufino, Pallavi Krishnamurthy
article en

Abstract

The study demonstrates a significant reduction in the number of cumulative tests needed to diagnose HIV accurately while remaining cost neutral to payers using the alternative algorithm. These findings suggest that the proposed alternative algorithm can streamline HIV testing without a substantial increase in healthcare costs and minimize adverse patient outcomes.

Clinical Infectious DiseasesVol. 81(2)
Roche (United States) (US), Center for Global Development (US), IQVIA (United States) (US), Health Economics and Outcomes Research (United Kingdom) (GB), Indiana University – Purdue University Indianapolis (US), La Roche College (US)
Openalex Percentile: Top 98%
HIV/AIDS Impact and Responses
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Estimating the Economic Consequences of Leveraging the Novel cobas HIV-1/HIV-2 Qualitative Nucleic Acid Amplification Test in Routine HIV Testing — James Karichu, Sara J. Blosser, et al. · Clinical Infectious Diseases (2025) | TGRS Research Map | TGRS